Panacea Index Logo

Command Palette

Search for a command to run...

Molecular Role of EGFR-MAPK Pathway in Patchouli Alcohol-Induced Apoptosis and Cell Cycle Arrest on A549 Cells In Vitro and In Vivo.

BioMed research international
May 5, 2016
XinGang Lu et al. (10 authors)
Journal ArticleHuman StudyMolecular Study
Extracted Claims (5)
InterventionDirectionEndpointPopulationDosageImpactClaim #
patchouli alcohol
decrease
human lung cancer A549 cells
in vitro
-
exerted antitumor ability
#1
patchouli alcohol
decrease
human lung cancer A549 cells
in vivo
-
exerted antitumor ability
#2
patchouli alcohol
increase
caspase 9
human lung cancer A549 cells
-
activated
#3
patchouli alcohol
increase
caspase 3
human lung cancer A549 cells
-
activated
#4
patchouli alcohol
decrease
xenograft tumor
in vivo
-
inhibited
#5
Abstract

Nowadays, chemotherapy is still the main effective treatment for cancer. Herb prescriptions containing Pogostemon cablin Benth (also known as "Guang-Huo-Xiang") have been widely used in Chinese medicine today. In our research, we found that patchouli alcohol, a compound isolated from the oil of Pogostemon cablin Benth, exerted antitumor ability against human lung cancer A549 cells ability both in vitro and in vivo. MTT assay was used to assess cell viability. Hoechst 33342 staining and TUNEL cover glass staining provided the visual evidence of apoptosis. Caspase activity measurement showed that patchouli alcohol activated caspase 9 and caspase 3 of mitochondria-mediated apoptosis. Consistently, patchouli alcohol inhibited the xenograft tumor in vivo. Further investigation of the underlying molecular mechanism showed that MAPK and EGFR pathway might contribute to the antitumor effect of patchouli alcohol. Our study proved that patchouli alcohol might be able to serve as a novel antitumor compound in the clinical treatment of lung cancer.

Medical Subject Headings (MeSH)
A549 CellsAnimalsApoptosisCell ProliferationCell SurvivalHumansLung NeoplasmsMedicine, Chinese TraditionalMicePogostemonSesquiterpenesXenograft Model Antitumor Assays
Study Links
Citation Metrics
Total Citations19
Citations/Year2.1
Relative Citation Ratio0.88
NIH Percentile45.6%
Research Impact Scores
APT Score0.05
Related Supplements